Litcius/Paper detail

COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar

Adeel A. Butt, Soha R. Dargham, Patrick Tang, Hiam Chemaitelly, Mohammad R. Hasan, Peter Coyle, Anvar Hassan Kaleeckal, Ali Nizar Latif, Srusvin Loka, Riyazuddin Mohammad Shaik, Ahmed Zaqout, Muna Almaslamani, Abdullatif Al Khal, Roberto Bertollini, Abdul‐Badi Abou‐Samra, Laith J. Abu‐Raddad

2022Journal of Global Health64 citationsDOIOpen Access PDF

Abstract

Background: Understanding the disease severity associated with the Omicron variant of the SARS-CoV-2 virus is important in determining appropriate management strategies at the individual and population levels. We determined the severity of SARS-CoV-2 infection in persons infected with the Omicron vs the Delta variant. Methods: We identified individuals with SARS-CoV-2 infection with Delta and propensity-score matched controls with Omicron variant infection from the National COVID-19 Database in Qatar. We excluded temporary visitors to Qatar, those with a prior documented infection, those ≤18 years old, and those with <14 days of follow up after the index test positive date. We determined the rates of admission to the hospital, admission to intensive care unit, mechanical ventilation, or death among those infected with the Delta or Omicron variants. Results: Among 9763 cases infected with the Delta variant and 11 310 cases infected with the Omicron variant, we identified 3926 propensity-score matched pairs. Among 3926 Delta infected, 3259 (83.0%) had mild, 633 (16.1%) had moderate and 34 (0.9%) had severe/critical disease. Among 3926 Omicron infected, 3866 (98.5%) had mild, 59 (1.5%) had moderate, and only 1 had severe/critical disease (overall P < 0.001). Factors associated with less moderate or severe/critical disease included infection with Omicron variant (aOR = 0.06; confidence interval (CI) = 0.05-0.09) and vaccination including a booster (aOR = 0.30; 95% CI = 0.09-0.99). Conclusions: Omicron variant infection is associated with significantly lower severity of disease compared with the Delta variant. Vaccination continues to offer strong protection against severe/critical disease.

Topics & Concepts

MedicineConfidence intervalIntensive care unitCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseasePopulationSeverity of illnessInternal medicineInfectious disease (medical specialty)Environmental healthSARS-CoV-2 and COVID-19 ResearchRespiratory viral infections researchSARS-CoV-2 detection and testing